カテゴリー： 世界, 医療/バイオ, LP Information

世界のガドリニウムベース造影剤市場予測 2023年-2029年

【英語タイトル】Global Gadolinium-based Contrast Media Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4766）・商品コード：LP23MY4766
・発行会社（調査会社）：LP Information
・発行日：2023年5月（※2025年版があります。お問い合わせください。）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のガドリニウムベース造影剤市場」は、過去の販売実績から2022年の世界のガドリニウムベース造影剤の総販売量を検討し、2023年から2029年の予測されるガドリニウムベース造影剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のガドリニウムベース造影剤の市場規模を掲載し、XXX百万米ドル規模の世界のガドリニウムベース造影剤市場の詳細な分析を提供します。本インサイトレポートは、世界のガドリニウムベース造影剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のガドリニウムベース造影剤市場における各社の独自のポジションをより深く理解するために、ガドリニウムベース造影剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のガドリニウムベース造影剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ガドリニウムベース造影剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ガドリニウムベース造影剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ガドリニウムベース造影剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ガドリニウムベース造影剤の世界主要メーカーとしては、Bayer AG、 GE Healthcare(GE)、 Guerbet、 Lantheus Medical Imaging、 Bracco Diagnostics Inc.、 Trivitron Healthcare、 Nano Therapeutics Pvt. Ltd.、 Nanoscan Imaging LLC、 Jodas Expoim Pvt Ltd、 Magnus Health(Veracross LLC)、 Spago Nanomedicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のガドリニウムベース造影剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではガドリニウムベース造影剤市場をセグメンテーションし、種類別 (細胞外用薬剤、血液プール用薬剤、肝胆道用薬剤)、用途別 (循環器、神経、がん、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：細胞外用薬剤、血液プール用薬剤、肝胆道用薬剤

・用途別区分：循環器、神経、がん、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のガドリニウムベース造影剤市場の10年間の市場状況・展望は？
・世界および地域別に見たガドリニウムベース造影剤市場成長の要因は何か？
・ガドリニウムベース造影剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・ガドリニウムベース造影剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ガドリニウムベース造影剤の年間販売量2018-2029、地域別現状・将来分析
・ガドリニウムベース造影剤の種類別セグメント：細胞外用薬剤、血液プール用薬剤、肝胆道用薬剤
・ガドリニウムベース造影剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ガドリニウムベース造影剤の用途別セグメント：循環器、神経、がん、その他
・ガドリニウムベース造影剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のガドリニウムベース造影剤市場
・企業別のグローバルガドリニウムベース造影剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のガドリニウムベース造影剤の年間売上：2018-2023年の売上、市場シェア
・企業別のガドリニウムベース造影剤販売価格
・主要企業のガドリニウムベース造影剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ガドリニウムベース造影剤の地域別レビュー
・地域別のガドリニウムベース造影剤市場規模2018-2023：年間販売量、売上
・主要国別のガドリニウムベース造影剤市場規模2018-2023：年間販売量、売上
・南北アメリカのガドリニウムベース造影剤販売の成長
・アジア太平洋のガドリニウムベース造影剤販売の成長
・ヨーロッパのガドリニウムベース造影剤販売の成長
・中東・アフリカのガドリニウムベース造影剤販売の成長

南北アメリカ市場
・南北アメリカの国別のガドリニウムベース造影剤販売量、売上（2018-2023）
・南北アメリカのガドリニウムベース造影剤の種類別販売量
・南北アメリカのガドリニウムベース造影剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のガドリニウムベース造影剤販売量、売上（2018-2023）
・アジア太平洋のガドリニウムベース造影剤の種類別販売量
・アジア太平洋のガドリニウムベース造影剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のガドリニウムベース造影剤販売量、売上（2018-2023）
・ヨーロッパのガドリニウムベース造影剤の種類別販売量
・ヨーロッパのガドリニウムベース造影剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のガドリニウムベース造影剤販売量、売上（2018-2023）
・中東・アフリカのガドリニウムベース造影剤の種類別販売量
・中東・アフリカのガドリニウムベース造影剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ガドリニウムベース造影剤の製造コスト構造分析
・ガドリニウムベース造影剤の製造プロセス分析
・ガドリニウムベース造影剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ガドリニウムベース造影剤の主要なグローバル販売業者
・ガドリニウムベース造影剤の主要なグローバル顧客

地域別のガドリニウムベース造影剤市場予測レビュー
・地域別のガドリニウムベース造影剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ガドリニウムベース造影剤の種類別市場規模予測
・ガドリニウムベース造影剤の用途別市場規模予測

主要企業分析
Bayer AG、 GE Healthcare(GE)、 Guerbet、 Lantheus Medical Imaging、 Bracco Diagnostics Inc.、 Trivitron Healthcare、 Nano Therapeutics Pvt. Ltd.、 Nanoscan Imaging LLC、 Jodas Expoim Pvt Ltd、 Magnus Health(Veracross LLC)、 Spago Nanomedical
・企業情報
・ガドリニウムベース造影剤製品
・ガドリニウムベース造影剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Gadolinium-based contrast media also referred to magnetic resonance imaging contrast media or dyes are chemical substances that are used in magnetic resonance imaging based diagnostics.
LPI (LP Information)’ newest research report, the “Gadolinium-based Contrast Media Industry Forecast” looks at past sales and reviews total world Gadolinium-based Contrast Media sales in 2022, providing a comprehensive analysis by region and market sector of projected Gadolinium-based Contrast Media sales for 2023 through 2029. With Gadolinium-based Contrast Media sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gadolinium-based Contrast Media industry.
This Insight Report provides a comprehensive analysis of the global Gadolinium-based Contrast Media landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gadolinium-based Contrast Media portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gadolinium-based Contrast Media market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gadolinium-based Contrast Media and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gadolinium-based Contrast Media.
The global Gadolinium-based Contrast Media market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gadolinium-based Contrast Media is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gadolinium-based Contrast Media is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gadolinium-based Contrast Media is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gadolinium-based Contrast Media players cover Bayer AG, GE Healthcare(GE), Guerbet, Lantheus Medical Imaging, Bracco Diagnostics Inc., Trivitron Healthcare, Nano Therapeutics Pvt. Ltd., Nanoscan Imaging LLC and Jodas Expoim Pvt Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gadolinium-based Contrast Media market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Extracellular Agents
Blood Pool Agents
Hepatobiliary Agents
Segmentation by application
Cardiovascular
Neurology
Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Bayer AG
GE Healthcare(GE)
Guerbet
Lantheus Medical Imaging
Bracco Diagnostics Inc.
Trivitron Healthcare
Nano Therapeutics Pvt. Ltd.
Nanoscan Imaging LLC
Jodas Expoim Pvt Ltd
Magnus Health(Veracross LLC)
Spago Nanomedical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gadolinium-based Contrast Media market?
What factors are driving Gadolinium-based Contrast Media market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gadolinium-based Contrast Media market opportunities vary by end market size?
How does Gadolinium-based Contrast Media break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gadolinium-based Contrast Media Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gadolinium-based Contrast Media by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gadolinium-based Contrast Media by Country/Region, 2018, 2022 & 2029
2.2 Gadolinium-based Contrast Media Segment by Type
2.2.1 Extracellular Agents
2.2.2 Blood Pool Agents
2.2.3 Hepatobiliary Agents
2.3 Gadolinium-based Contrast Media Sales by Type
2.3.1 Global Gadolinium-based Contrast Media Sales Market Share by Type (2018-2023)
2.3.2 Global Gadolinium-based Contrast Media Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gadolinium-based Contrast Media Sale Price by Type (2018-2023)
2.4 Gadolinium-based Contrast Media Segment by Application
2.4.1 Cardiovascular
2.4.2 Neurology
2.4.3 Cancer
2.4.4 Others
2.5 Gadolinium-based Contrast Media Sales by Application
2.5.1 Global Gadolinium-based Contrast Media Sale Market Share by Application (2018-2023)
2.5.2 Global Gadolinium-based Contrast Media Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gadolinium-based Contrast Media Sale Price by Application (2018-2023)
3 Global Gadolinium-based Contrast Media by Company
3.1 Global Gadolinium-based Contrast Media Breakdown Data by Company
3.1.1 Global Gadolinium-based Contrast Media Annual Sales by Company (2018-2023)
3.1.2 Global Gadolinium-based Contrast Media Sales Market Share by Company (2018-2023)
3.2 Global Gadolinium-based Contrast Media Annual Revenue by Company (2018-2023)
3.2.1 Global Gadolinium-based Contrast Media Revenue by Company (2018-2023)
3.2.2 Global Gadolinium-based Contrast Media Revenue Market Share by Company (2018-2023)
3.3 Global Gadolinium-based Contrast Media Sale Price by Company
3.4 Key Manufacturers Gadolinium-based Contrast Media Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gadolinium-based Contrast Media Product Location Distribution
3.4.2 Players Gadolinium-based Contrast Media Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gadolinium-based Contrast Media by Geographic Region
4.1 World Historic Gadolinium-based Contrast Media Market Size by Geographic Region (2018-2023)
4.1.1 Global Gadolinium-based Contrast Media Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gadolinium-based Contrast Media Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gadolinium-based Contrast Media Market Size by Country/Region (2018-2023)
4.2.1 Global Gadolinium-based Contrast Media Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gadolinium-based Contrast Media Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gadolinium-based Contrast Media Sales Growth
4.4 APAC Gadolinium-based Contrast Media Sales Growth
4.5 Europe Gadolinium-based Contrast Media Sales Growth
4.6 Middle East & Africa Gadolinium-based Contrast Media Sales Growth
5 Americas
5.1 Americas Gadolinium-based Contrast Media Sales by Country
5.1.1 Americas Gadolinium-based Contrast Media Sales by Country (2018-2023)
5.1.2 Americas Gadolinium-based Contrast Media Revenue by Country (2018-2023)
5.2 Americas Gadolinium-based Contrast Media Sales by Type
5.3 Americas Gadolinium-based Contrast Media Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gadolinium-based Contrast Media Sales by Region
6.1.1 APAC Gadolinium-based Contrast Media Sales by Region (2018-2023)
6.1.2 APAC Gadolinium-based Contrast Media Revenue by Region (2018-2023)
6.2 APAC Gadolinium-based Contrast Media Sales by Type
6.3 APAC Gadolinium-based Contrast Media Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gadolinium-based Contrast Media by Country
7.1.1 Europe Gadolinium-based Contrast Media Sales by Country (2018-2023)
7.1.2 Europe Gadolinium-based Contrast Media Revenue by Country (2018-2023)
7.2 Europe Gadolinium-based Contrast Media Sales by Type
7.3 Europe Gadolinium-based Contrast Media Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gadolinium-based Contrast Media by Country
8.1.1 Middle East & Africa Gadolinium-based Contrast Media Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gadolinium-based Contrast Media Revenue by Country (2018-2023)
8.2 Middle East & Africa Gadolinium-based Contrast Media Sales by Type
8.3 Middle East & Africa Gadolinium-based Contrast Media Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gadolinium-based Contrast Media
10.3 Manufacturing Process Analysis of Gadolinium-based Contrast Media
10.4 Industry Chain Structure of Gadolinium-based Contrast Media
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gadolinium-based Contrast Media Distributors
11.3 Gadolinium-based Contrast Media Customer
12 World Forecast Review for Gadolinium-based Contrast Media by Geographic Region
12.1 Global Gadolinium-based Contrast Media Market Size Forecast by Region
12.1.1 Global Gadolinium-based Contrast Media Forecast by Region (2024-2029)
12.1.2 Global Gadolinium-based Contrast Media Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gadolinium-based Contrast Media Forecast by Type
12.7 Global Gadolinium-based Contrast Media Forecast by Application
13 Key Players Analysis
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Gadolinium-based Contrast Media Product Portfolios and Specifications
13.1.3 Bayer AG Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 GE Healthcare(GE)
13.2.1 GE Healthcare(GE) Company Information
13.2.2 GE Healthcare(GE) Gadolinium-based Contrast Media Product Portfolios and Specifications
13.2.3 GE Healthcare(GE) Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GE Healthcare(GE) Main Business Overview
13.2.5 GE Healthcare(GE) Latest Developments
13.3 Guerbet
13.3.1 Guerbet Company Information
13.3.2 Guerbet Gadolinium-based Contrast Media Product Portfolios and Specifications
13.3.3 Guerbet Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Guerbet Main Business Overview
13.3.5 Guerbet Latest Developments
13.4 Lantheus Medical Imaging
13.4.1 Lantheus Medical Imaging Company Information
13.4.2 Lantheus Medical Imaging Gadolinium-based Contrast Media Product Portfolios and Specifications
13.4.3 Lantheus Medical Imaging Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lantheus Medical Imaging Main Business Overview
13.4.5 Lantheus Medical Imaging Latest Developments
13.5 Bracco Diagnostics Inc.
13.5.1 Bracco Diagnostics Inc. Company Information
13.5.2 Bracco Diagnostics Inc. Gadolinium-based Contrast Media Product Portfolios and Specifications
13.5.3 Bracco Diagnostics Inc. Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bracco Diagnostics Inc. Main Business Overview
13.5.5 Bracco Diagnostics Inc. Latest Developments
13.6 Trivitron Healthcare
13.6.1 Trivitron Healthcare Company Information
13.6.2 Trivitron Healthcare Gadolinium-based Contrast Media Product Portfolios and Specifications
13.6.3 Trivitron Healthcare Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Trivitron Healthcare Main Business Overview
13.6.5 Trivitron Healthcare Latest Developments
13.7 Nano Therapeutics Pvt. Ltd.
13.7.1 Nano Therapeutics Pvt. Ltd. Company Information
13.7.2 Nano Therapeutics Pvt. Ltd. Gadolinium-based Contrast Media Product Portfolios and Specifications
13.7.3 Nano Therapeutics Pvt. Ltd. Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nano Therapeutics Pvt. Ltd. Main Business Overview
13.7.5 Nano Therapeutics Pvt. Ltd. Latest Developments
13.8 Nanoscan Imaging LLC
13.8.1 Nanoscan Imaging LLC Company Information
13.8.2 Nanoscan Imaging LLC Gadolinium-based Contrast Media Product Portfolios and Specifications
13.8.3 Nanoscan Imaging LLC Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Nanoscan Imaging LLC Main Business Overview
13.8.5 Nanoscan Imaging LLC Latest Developments
13.9 Jodas Expoim Pvt Ltd
13.9.1 Jodas Expoim Pvt Ltd Company Information
13.9.2 Jodas Expoim Pvt Ltd Gadolinium-based Contrast Media Product Portfolios and Specifications
13.9.3 Jodas Expoim Pvt Ltd Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Jodas Expoim Pvt Ltd Main Business Overview
13.9.5 Jodas Expoim Pvt Ltd Latest Developments
13.10 Magnus Health(Veracross LLC)
13.10.1 Magnus Health(Veracross LLC) Company Information
13.10.2 Magnus Health(Veracross LLC) Gadolinium-based Contrast Media Product Portfolios and Specifications
13.10.3 Magnus Health(Veracross LLC) Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Magnus Health(Veracross LLC) Main Business Overview
13.10.5 Magnus Health(Veracross LLC) Latest Developments
13.11 Spago Nanomedical
13.11.1 Spago Nanomedical Company Information
13.11.2 Spago Nanomedical Gadolinium-based Contrast Media Product Portfolios and Specifications
13.11.3 Spago Nanomedical Gadolinium-based Contrast Media Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Spago Nanomedical Main Business Overview
13.11.5 Spago Nanomedical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Gadolinium-based Contrast Media Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gadolinium-based Contrast Media Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Extracellular Agents
Table 4. Major Players of Blood Pool Agents
Table 5. Major Players of Hepatobiliary Agents
Table 6. Global Gadolinium-based Contrast Media Sales by Type (2018-2023) & (K Units)
Table 7. Global Gadolinium-based Contrast Media Sales Market Share by Type (2018-2023)
Table 8. Global Gadolinium-based Contrast Media Revenue by Type (2018-2023) & ($ million)
Table 9. Global Gadolinium-based Contrast Media Revenue Market Share by Type (2018-2023)
Table 10. Global Gadolinium-based Contrast Media Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Gadolinium-based Contrast Media Sales by Application (2018-2023) & (K Units)
Table 12. Global Gadolinium-based Contrast Media Sales Market Share by Application (2018-2023)
Table 13. Global Gadolinium-based Contrast Media Revenue by Application (2018-2023)
Table 14. Global Gadolinium-based Contrast Media Revenue Market Share by Application (2018-2023)
Table 15. Global Gadolinium-based Contrast Media Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Gadolinium-based Contrast Media Sales by Company (2018-2023) & (K Units)
Table 17. Global Gadolinium-based Contrast Media Sales Market Share by Company (2018-2023)
Table 18. Global Gadolinium-based Contrast Media Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Gadolinium-based Contrast Media Revenue Market Share by Company (2018-2023)
Table 20. Global Gadolinium-based Contrast Media Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Gadolinium-based Contrast Media Producing Area Distribution and Sales Area
Table 22. Players Gadolinium-based Contrast Media Products Offered
Table 23. Gadolinium-based Contrast Media Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Gadolinium-based Contrast Media Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Gadolinium-based Contrast Media Sales Market Share Geographic Region (2018-2023)
Table 28. Global Gadolinium-based Contrast Media Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Gadolinium-based Contrast Media Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Gadolinium-based Contrast Media Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Gadolinium-based Contrast Media Sales Market Share by Country/Region (2018-2023)
Table 32. Global Gadolinium-based Contrast Media Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Gadolinium-based Contrast Media Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Gadolinium-based Contrast Media Sales by Country (2018-2023) & (K Units)
Table 35. Americas Gadolinium-based Contrast Media Sales Market Share by Country (2018-2023)
Table 36. Americas Gadolinium-based Contrast Media Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Gadolinium-based Contrast Media Revenue Market Share by Country (2018-2023)
Table 38. Americas Gadolinium-based Contrast Media Sales by Type (2018-2023) & (K Units)
Table 39. Americas Gadolinium-based Contrast Media Sales by Application (2018-2023) & (K Units)
Table 40. APAC Gadolinium-based Contrast Media Sales by Region (2018-2023) & (K Units)
Table 41. APAC Gadolinium-based Contrast Media Sales Market Share by Region (2018-2023)
Table 42. APAC Gadolinium-based Contrast Media Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Gadolinium-based Contrast Media Revenue Market Share by Region (2018-2023)
Table 44. APAC Gadolinium-based Contrast Media Sales by Type (2018-2023) & (K Units)
Table 45. APAC Gadolinium-based Contrast Media Sales by Application (2018-2023) & (K Units)
Table 46. Europe Gadolinium-based Contrast Media Sales by Country (2018-2023) & (K Units)
Table 47. Europe Gadolinium-based Contrast Media Sales Market Share by Country (2018-2023)
Table 48. Europe Gadolinium-based Contrast Media Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Gadolinium-based Contrast Media Revenue Market Share by Country (2018-2023)
Table 50. Europe Gadolinium-based Contrast Media Sales by Type (2018-2023) & (K Units)
Table 51. Europe Gadolinium-based Contrast Media Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Gadolinium-based Contrast Media Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Gadolinium-based Contrast Media Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Gadolinium-based Contrast Media Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Gadolinium-based Contrast Media Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Gadolinium-based Contrast Media Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Gadolinium-based Contrast Media Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Gadolinium-based Contrast Media
Table 59. Key Market Challenges & Risks of Gadolinium-based Contrast Media
Table 60. Key Industry Trends of Gadolinium-based Contrast Media
Table 61. Gadolinium-based Contrast Media Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Gadolinium-based Contrast Media Distributors List
Table 64. Gadolinium-based Contrast Media Customer List
Table 65. Global Gadolinium-based Contrast Media Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Gadolinium-based Contrast Media Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Gadolinium-based Contrast Media Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Gadolinium-based Contrast Media Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Gadolinium-based Contrast Media Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Gadolinium-based Contrast Media Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Gadolinium-based Contrast Media Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Gadolinium-based Contrast Media Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Gadolinium-based Contrast Media Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Gadolinium-based Contrast Media Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Gadolinium-based Contrast Media Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Gadolinium-based Contrast Media Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Gadolinium-based Contrast Media Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Gadolinium-based Contrast Media Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Bayer AG Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 80. Bayer AG Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 81. Bayer AG Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Bayer AG Main Business
Table 83. Bayer AG Latest Developments
Table 84. GE Healthcare(GE) Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 85. GE Healthcare(GE) Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 86. GE Healthcare(GE) Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. GE Healthcare(GE) Main Business
Table 88. GE Healthcare(GE) Latest Developments
Table 89. Guerbet Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 90. Guerbet Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 91. Guerbet Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Guerbet Main Business
Table 93. Guerbet Latest Developments
Table 94. Lantheus Medical Imaging Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 95. Lantheus Medical Imaging Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 96. Lantheus Medical Imaging Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Lantheus Medical Imaging Main Business
Table 98. Lantheus Medical Imaging Latest Developments
Table 99. Bracco Diagnostics Inc. Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 100. Bracco Diagnostics Inc. Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 101. Bracco Diagnostics Inc. Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Bracco Diagnostics Inc. Main Business
Table 103. Bracco Diagnostics Inc. Latest Developments
Table 104. Trivitron Healthcare Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 105. Trivitron Healthcare Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 106. Trivitron Healthcare Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Trivitron Healthcare Main Business
Table 108. Trivitron Healthcare Latest Developments
Table 109. Nano Therapeutics Pvt. Ltd. Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 110. Nano Therapeutics Pvt. Ltd. Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 111. Nano Therapeutics Pvt. Ltd. Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Nano Therapeutics Pvt. Ltd. Main Business
Table 113. Nano Therapeutics Pvt. Ltd. Latest Developments
Table 114. Nanoscan Imaging LLC Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 115. Nanoscan Imaging LLC Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 116. Nanoscan Imaging LLC Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Nanoscan Imaging LLC Main Business
Table 118. Nanoscan Imaging LLC Latest Developments
Table 119. Jodas Expoim Pvt Ltd Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 120. Jodas Expoim Pvt Ltd Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 121. Jodas Expoim Pvt Ltd Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Jodas Expoim Pvt Ltd Main Business
Table 123. Jodas Expoim Pvt Ltd Latest Developments
Table 124. Magnus Health(Veracross LLC) Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 125. Magnus Health(Veracross LLC) Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 126. Magnus Health(Veracross LLC) Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Magnus Health(Veracross LLC) Main Business
Table 128. Magnus Health(Veracross LLC) Latest Developments
Table 129. Spago Nanomedical Basic Information, Gadolinium-based Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 130. Spago Nanomedical Gadolinium-based Contrast Media Product Portfolios and Specifications
Table 131. Spago Nanomedical Gadolinium-based Contrast Media Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Spago Nanomedical Main Business
Table 133. Spago Nanomedical Latest Developments
List of Figures
Figure 1. Picture of Gadolinium-based Contrast Media
Figure 2. Gadolinium-based Contrast Media Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gadolinium-based Contrast Media Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gadolinium-based Contrast Media Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gadolinium-based Contrast Media Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Extracellular Agents
Figure 10. Product Picture of Blood Pool Agents
Figure 11. Product Picture of Hepatobiliary Agents
Figure 12. Global Gadolinium-based Contrast Media Sales Market Share by Type in 2022
Figure 13. Global Gadolinium-based Contrast Media Revenue Market Share by Type (2018-2023)
Figure 14. Gadolinium-based Contrast Media Consumed in Cardiovascular
Figure 15. Global Gadolinium-based Contrast Media Market: Cardiovascular (2018-2023) & (K Units)
Figure 16. Gadolinium-based Contrast Media Consumed in Neurology
Figure 17. Global Gadolinium-based Contrast Media Market: Neurology (2018-2023) & (K Units)
Figure 18. Gadolinium-based Contrast Media Consumed in Cancer
Figure 19. Global Gadolinium-based Contrast Media Market: Cancer (2018-2023) & (K Units)
Figure 20. Gadolinium-based Contrast Media Consumed in Others
Figure 21. Global Gadolinium-based Contrast Media Market: Others (2018-2023) & (K Units)
Figure 22. Global Gadolinium-based Contrast Media Sales Market Share by Application (2022)
Figure 23. Global Gadolinium-based Contrast Media Revenue Market Share by Application in 2022
Figure 24. Gadolinium-based Contrast Media Sales Market by Company in 2022 (K Units)
Figure 25. Global Gadolinium-based Contrast Media Sales Market Share by Company in 2022
Figure 26. Gadolinium-based Contrast Media Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Gadolinium-based Contrast Media Revenue Market Share by Company in 2022
Figure 28. Global Gadolinium-based Contrast Media Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Gadolinium-based Contrast Media Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Gadolinium-based Contrast Media Sales 2018-2023 (K Units)
Figure 31. Americas Gadolinium-based Contrast Media Revenue 2018-2023 ($ Millions)
Figure 32. APAC Gadolinium-based Contrast Media Sales 2018-2023 (K Units)
Figure 33. APAC Gadolinium-based Contrast Media Revenue 2018-2023 ($ Millions)
Figure 34. Europe Gadolinium-based Contrast Media Sales 2018-2023 (K Units)
Figure 35. Europe Gadolinium-based Contrast Media Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Gadolinium-based Contrast Media Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Gadolinium-based Contrast Media Revenue 2018-2023 ($ Millions)
Figure 38. Americas Gadolinium-based Contrast Media Sales Market Share by Country in 2022
Figure 39. Americas Gadolinium-based Contrast Media Revenue Market Share by Country in 2022
Figure 40. Americas Gadolinium-based Contrast Media Sales Market Share by Type (2018-2023)
Figure 41. Americas Gadolinium-based Contrast Media Sales Market Share by Application (2018-2023)
Figure 42. United States Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Gadolinium-based Contrast Media Sales Market Share by Region in 2022
Figure 47. APAC Gadolinium-based Contrast Media Revenue Market Share by Regions in 2022
Figure 48. APAC Gadolinium-based Contrast Media Sales Market Share by Type (2018-2023)
Figure 49. APAC Gadolinium-based Contrast Media Sales Market Share by Application (2018-2023)
Figure 50. China Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Gadolinium-based Contrast Media Sales Market Share by Country in 2022
Figure 58. Europe Gadolinium-based Contrast Media Revenue Market Share by Country in 2022
Figure 59. Europe Gadolinium-based Contrast Media Sales Market Share by Type (2018-2023)
Figure 60. Europe Gadolinium-based Contrast Media Sales Market Share by Application (2018-2023)
Figure 61. Germany Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Gadolinium-based Contrast Media Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Gadolinium-based Contrast Media Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Gadolinium-based Contrast Media Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Gadolinium-based Contrast Media Sales Market Share by Application (2018-2023)
Figure 70. Egypt Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Gadolinium-based Contrast Media Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Gadolinium-based Contrast Media in 2022
Figure 76. Manufacturing Process Analysis of Gadolinium-based Contrast Media
Figure 77. Industry Chain Structure of Gadolinium-based Contrast Media
Figure 78. Channels of Distribution
Figure 79. Global Gadolinium-based Contrast Media Sales Market Forecast by Region (2024-2029)
Figure 80. Global Gadolinium-based Contrast Media Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Gadolinium-based Contrast Media Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Gadolinium-based Contrast Media Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Gadolinium-based Contrast Media Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Gadolinium-based Contrast Media Revenue Market Share Forecast by Application (2024-2029)

※参考情報

ガドリニウムベース造影剤は、医療診断の分野、特に画像診断において非常に重要な役割を果たしています。これらの造影剤は主に磁気共鳴画像法（MRI）において使用され、体内の構造物や疾患を詳しく可視化するために利用されます。ガドリニウムは、周期表の第3周期に属する希土類元素であり、その特性から造影剤としての使用が特に注目されています。

ガドリニウムベース造影剤の主な特徴は、高い磁気親和性を持っていることです。この特性により、ガドリニウムはMRIスキャン中に強い信号を生成し、周囲の組織とのコントラストを形成することができます。これにより、医師は脳、脊髄、心臓、血管、関節、腫瘍などの詳細な画像を得ることができ、的確な診断を下す手助けとなります。

ガドリニウムベース造影剤は、主に以下のような種類に分類されます。第一に、非イオン性造影剤があります。これは水溶性であり、体内での使用時に副作用のリスクが低いとされます。第二に、イオン性造影剤があります。こちらは体内に注入された際に膨張するため、血管の観察に適していますが、非イオン性よりも副作用のリスクが高いとされています。また、ガドリニウムベース造影剤は、患者の腎機能に応じて使用されることが多いです。急性腎不全や慢性腎疾患を持つ患者に対しては、特に注意が必要です。

造影剤の具体的な用途は多岐にわたりますが、主に画像のコントラストを高めることを目的としています。脳の病変、脊髄の異常、関節疾患、心臓病、腫瘍などの診断において、ガドリニウムベース造影剤は不可欠な存在です。たとえば、脳のMRIスキャンでは、脳腫瘍や脳梗塞、動脈瘤などを明確に視覚化することが可能です。また、心臓MRIにおいては、心筋の血流や障害の評価、心臓の構造的な異常の診断に用いられます。

近年では、ガドリニウムベース造影剤の使用に伴うリスクも指摘されています。特に、全身性線維症（NSF）のリスクが高いとされる患者、特に腎機能が低下している患者においては、使用が慎重に行われます。このため、医療現場では必ず患者の健康状態や病歴を考慮した上で、造影剤の使用が決定されます。

関連技術としては、MRI機器自体の進化があります。例えば、より高性能なMRI機器が開発されることにより、画像の解像度が向上しており、ガドリニウムベース造影剤の効果を最大限に引き出すことが可能です。また、造影剤の投与方法やタイミングを最適化するための技術も進化しており、リアルタイムでの画像処理や解析技術が導入されています。

さらに、MRI以外の画像診断法においてもガドリニウムベース造影剤の応用が試みられているケースが増えています。CT（コンピュータ断層撮影）における造影剤の使用や、超音波検査におけるガドリニウムを用いた技術も研究されています。

最後に、今後の研究動向として、新しいタイプの造影剤の開発が期待されています。これには、より安全性が高く、副作用の少ない新しい化合物や、特定の疾患に特化した選択的な造影剤の開発が含まれます。ガドリニウムベース造影剤を使用することで、より詳細で正確な診断が可能となり、患者の治療においても大きな影響を与えることが期待されています。

総じて、ガドリニウムベース造影剤は現代医療において不可欠な存在であり、多くの患者に利益をもたらしています。これらの造影剤は、医療診断の精度を向上させ、臨床現場における重要な道具としての役割を果たしています。


★調査レポート[世界のガドリニウムベース造影剤市場予測 2023年-2029年] (コード：LP23MY4766)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のガドリニウムベース造影剤市場予測 2023年-2029年]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆